Imugene Limited (IMU.AX)
AUD 0.04
(-5.26%)
AUD 0.04
(-5.26%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -140.93 Million AUD | -174.75% |
| 2023 | -51.29 Million AUD | -1.22% |
| 2022 | -50.67 Million AUD | -97.43% |
| 2021 | -25.66 Million AUD | -72.5% |
| 2020 | -14.87 Million AUD | -20.1% |
| 2019 | -12.38 Million AUD | -114.42% |
| 2018 | -5.77 Million AUD | -56.8% |
| 2017 | -3.68 Million AUD | 13.68% |
| 2016 | -4.26 Million AUD | -90.07% |
| 2015 | -2.24 Million AUD | -181.62% |
| 2014 | -797.49 Thousand AUD | 54.15% |
| 2013 | -1.73 Million AUD | -49.0% |
| 2012 | -1.16 Million AUD | -444.44% |
| 2011 | 338.93 Thousand AUD | 115.96% |
| 2010 | -2.12 Million AUD | 23.01% |
| 2009 | -2.75 Million AUD | -7.7% |
| 2008 | -2.56 Million AUD | 15.8% |
| 2007 | -3.04 Million AUD | 3.54% |
| 2006 | -3.15 Million AUD | -25.44% |
| 2005 | -2.51 Million AUD | 13.84% |
| 2004 | -2.91 Million AUD | -20.1% |
| 2003 | -2.42 Million AUD | -408.3% |
| 2002 | 787.71 Thousand AUD | 130.64% |
| 2001 | -2.57 Million AUD | 41.58% |
| 2000 | -4.4 Million AUD | 10.24% |
| 1999 | -4.9 Million AUD | -8.52% |
| 1998 | -4.51 Million AUD | -217.08% |
| 1997 | 3.85 Million AUD | 750.76% |
| 1996 | -593 Thousand AUD | 20.62% |
| 1995 | -747 Thousand AUD | 2.48% |
| 1994 | -766 Thousand AUD | -192.37% |
| 1993 | -262 Thousand AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q4 | -67.55 Million AUD | 0.0% |
| 2024 FY | -140.93 Million AUD | -174.75% |
| 2024 Q2 | -79.23 Million AUD | 0.0% |
| 2023 FY | -51.29 Million AUD | -1.22% |
| 2023 Q4 | -29.38 Million AUD | 0.0% |
| 2023 Q2 | -21.9 Million AUD | 0.0% |
| 2022 Q4 | -30.15 Million AUD | 0.0% |
| 2022 FY | -50.67 Million AUD | -97.43% |
| 2022 Q2 | -20.52 Million AUD | 0.0% |
| 2021 FY | -25.66 Million AUD | -72.5% |
| 2021 Q2 | -10.14 Million AUD | 0.0% |
| 2021 Q4 | -15.52 Million AUD | 0.0% |
| 2020 Q2 | -7.25 Million AUD | 0.0% |
| 2020 FY | -14.87 Million AUD | -20.1% |
| 2020 Q4 | -7.62 Million AUD | 0.0% |
| 2019 Q2 | -3.73 Million AUD | 0.0% |
| 2019 FY | -12.38 Million AUD | -114.42% |
| 2019 Q4 | -7.03 Million AUD | 0.0% |
| 2018 Q2 | -1.64 Million AUD | 0.0% |
| 2018 FY | -5.77 Million AUD | -56.8% |
| 2018 Q4 | -2.29 Million AUD | 0.0% |
| 2017 Q2 | -1.48 Million AUD | 0.0% |
| 2017 FY | -3.68 Million AUD | 13.68% |
| 2017 Q4 | -1.03 Million AUD | 0.0% |
| 2016 FY | -4.26 Million AUD | -90.07% |
| 2016 Q4 | -1.62 Million AUD | 0.0% |
| 2016 Q2 | -1.07 Million AUD | 0.0% |
| 2015 Q2 | -1 Million AUD | 0.0% |
| 2015 FY | -2.24 Million AUD | -181.62% |
| 2015 Q4 | -1.23 Million AUD | 0.0% |
| 2014 Q2 | -534.88 Thousand AUD | 0.0% |
| 2014 FY | -797.49 Thousand AUD | 54.15% |
| 2014 Q4 | -262.6 Thousand AUD | 0.0% |
| 2013 Q3 | -434.85 Thousand AUD | 64.04% |
| 2013 Q4 | -322.88 Thousand AUD | 25.75% |
| 2013 Q2 | -1.2 Million AUD | -314.36% |
| 2013 Q1 | -291.85 Thousand AUD | 0.0% |
| 2013 FY | -1.73 Million AUD | -49.0% |
| 2012 FY | -1.16 Million AUD | -444.44% |
| 2012 Q4 | -291.85 Thousand AUD | 0.0% |
| 2012 Q3 | -291.85 Thousand AUD | 0.0% |
| 2012 Q2 | -291.85 Thousand AUD | -442.41% |
| 2012 Q1 | 85.23 Thousand AUD | 0.0% |
| 2011 FY | 338.93 Thousand AUD | 115.96% |
| 2011 Q4 | 85.23 Thousand AUD | 0.0% |
| 2011 Q3 | 85.23 Thousand AUD | 0.0% |
| 2011 Q2 | 85.23 Thousand AUD | 116.07% |
| 2011 Q1 | -530.29 Thousand AUD | 0.0% |
| 2010 Q1 | -688.84 Thousand AUD | 0.0% |
| 2010 Q2 | -530.29 Thousand AUD | 23.02% |
| 2010 Q4 | -530.29 Thousand AUD | 0.0% |
| 2010 Q3 | -530.29 Thousand AUD | 0.0% |
| 2010 FY | -2.12 Million AUD | 23.01% |
| 2009 Q2 | -688.84 Thousand AUD | -7.74% |
| 2009 Q4 | -688.84 Thousand AUD | 0.0% |
| 2009 Q3 | -688.84 Thousand AUD | 0.0% |
| 2009 FY | -2.75 Million AUD | -7.7% |
| 2009 Q1 | -639.37 Thousand AUD | 0.0% |
| 2008 Q1 | -758.99 Thousand AUD | 0.0% |
| 2008 FY | -2.56 Million AUD | 15.8% |
| 2008 Q4 | -639.37 Thousand AUD | 0.0% |
| 2008 Q3 | -639.37 Thousand AUD | 0.0% |
| 2008 Q2 | -639.37 Thousand AUD | 15.76% |
| 2007 Q2 | -758.99 Thousand AUD | -8.21% |
| 2007 Q4 | -758.99 Thousand AUD | 0.0% |
| 2007 FY | -3.04 Million AUD | 3.54% |
| 2007 Q1 | -701.4 Thousand AUD | 0.0% |
| 2007 Q3 | -758.99 Thousand AUD | 0.0% |
| 2006 Q3 | -701.4 Thousand AUD | 0.0% |
| 2006 FY | -3.15 Million AUD | -25.44% |
| 2006 Q4 | -701.4 Thousand AUD | 0.0% |
| 2006 Q2 | -701.4 Thousand AUD | -11.93% |
| 2006 Q1 | -626.61 Thousand AUD | 0.0% |
| 2005 FY | -2.51 Million AUD | 13.84% |
| 2005 Q4 | -626.61 Thousand AUD | 0.0% |
| 2005 Q1 | -727.3 Thousand AUD | 0.0% |
| 2005 Q3 | -626.61 Thousand AUD | 0.0% |
| 2005 Q2 | -626.61 Thousand AUD | 13.84% |
| 2004 FY | -2.91 Million AUD | -20.1% |
| 2004 Q3 | -727.3 Thousand AUD | 0.0% |
| 2004 Q2 | -727.3 Thousand AUD | -26.69% |
| 2004 Q1 | -574.07 Thousand AUD | 0.0% |
| 2004 Q4 | -727.3 Thousand AUD | 0.0% |
| 2003 Q4 | -574.07 Thousand AUD | 0.0% |
| 2003 FY | -2.42 Million AUD | -408.3% |
| 2003 Q3 | -574.07 Thousand AUD | 0.0% |
| 2003 Q1 | 196.92 Thousand AUD | 0.0% |
| 2003 Q2 | -574.07 Thousand AUD | -391.52% |
| 2002 Q1 | -642.72 Thousand AUD | 0.0% |
| 2002 Q3 | 196.92 Thousand AUD | 0.0% |
| 2002 FY | 787.71 Thousand AUD | 130.64% |
| 2002 Q2 | 196.92 Thousand AUD | 130.64% |
| 2002 Q4 | 196.92 Thousand AUD | 0.0% |
| 2001 Q1 | -2.2 Million AUD | 0.0% |
| 2001 Q3 | -642.72 Thousand AUD | 0.0% |
| 2001 Q4 | -642.72 Thousand AUD | 0.0% |
| 2001 FY | -2.57 Million AUD | 41.58% |
| 2001 Q2 | -642.72 Thousand AUD | 70.85% |
| 2000 Q2 | -2.2 Million AUD | 10.29% |
| 2000 Q4 | -2.2 Million AUD | 0.0% |
| 2000 Q3 | -2.2 Million AUD | 0.0% |
| 2000 FY | -4.4 Million AUD | 10.24% |
| 2000 Q1 | -2.45 Million AUD | 0.0% |
| 1999 Q4 | -2.45 Million AUD | 0.0% |
| 1999 Q2 | -2.45 Million AUD | -8.48% |
| 1999 Q3 | -2.45 Million AUD | 0.0% |
| 1999 Q1 | -2.26 Million AUD | 0.0% |
| 1999 FY | -4.9 Million AUD | -8.52% |
| 1998 Q2 | -2.26 Million AUD | -334.88% |
| 1998 Q3 | -2.26 Million AUD | 0.0% |
| 1998 Q1 | 964.75 Thousand AUD | 0.0% |
| 1998 Q4 | -2.26 Million AUD | 0.0% |
| 1998 FY | -4.51 Million AUD | -217.08% |
| 1997 Q3 | 964.75 Thousand AUD | 0.0% |
| 1997 FY | 3.85 Million AUD | 750.76% |
| 1997 Q4 | 964.75 Thousand AUD | 0.0% |
| 1997 Q2 | 964.75 Thousand AUD | 750.76% |
| 1997 Q1 | -148.25 Thousand AUD | 0.0% |
| 1996 Q4 | -148.25 Thousand AUD | 0.0% |
| 1996 Q3 | -148.25 Thousand AUD | 0.0% |
| 1996 FY | -593 Thousand AUD | 20.62% |
| 1996 Q2 | -148.25 Thousand AUD | 20.62% |
| 1996 Q1 | -186.75 Thousand AUD | 0.0% |
| 1995 FY | -747 Thousand AUD | 2.48% |
| 1995 Q1 | -191.5 Thousand AUD | 0.0% |
| 1995 Q2 | -186.75 Thousand AUD | 2.48% |
| 1995 Q3 | -186.75 Thousand AUD | 0.0% |
| 1995 Q4 | -186.75 Thousand AUD | 0.0% |
| 1994 Q4 | -191.5 Thousand AUD | 0.0% |
| 1994 Q2 | -191.5 Thousand AUD | -192.37% |
| 1994 Q3 | -191.5 Thousand AUD | 0.0% |
| 1994 FY | -766 Thousand AUD | -192.37% |
| 1994 Q1 | -65.5 Thousand AUD | 0.0% |
| 1993 Q4 | -65.5 Thousand AUD | 0.0% |
| 1993 FY | -262 Thousand AUD | 0.0% |
| 1993 Q2 | -65.5 Thousand AUD | 0.0% |
| 1993 Q3 | -65.5 Thousand AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 9.71 Million AUD | 1550.417% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -9558.563% |
| Zelira Therapeutics Limited | -5.93 Million AUD | -2273.278% |
| Biome Australia Limited | -1.91 Million AUD | -7266.075% |
| Patrys Limited | -3.53 Million AUD | -3882.049% |
| Orthocell Limited | -11.68 Million AUD | -1106.483% |
| Noxopharm Limited | -7.53 Million AUD | -1770.347% |
| PYC Therapeutics Limited | -38.85 Million AUD | -262.689% |
| Chimeric Therapeutics Limited | -12.3 Million AUD | -1044.877% |
| Prescient Therapeutics Limited | -7.18 Million AUD | -1861.07% |
| Proteomics International Laboratories Limited | -7.23 Million AUD | -1848.832% |
| Cynata Therapeutics Limited | -8.8 Million AUD | -1500.045% |
| CSL Limited | 5.64 Billion AUD | 102.495% |
| Arovella Therapeutics Limited | -7.19 Million AUD | -1859.263% |
| Bio-Gene Technology Limited | -3.06 Million AUD | -4501.874% |
| Clinuvel Pharmaceuticals Limited | 49.14 Million AUD | 386.747% |
| Starpharma Holdings Limited | -15.15 Million AUD | -829.683% |
| Nanollose Limited | -1.24 Million AUD | -11176.034% |
| Memphasys Limited | -2.7 Million AUD | -5111.934% |
| Invex Therapeutics Ltd | -2.13 Million AUD | -6505.217% |
| NeuroScientific Biopharmaceuticals Limited | -2.05 Million AUD | -6752.739% |
| Amplia Therapeutics Limited | -4.42 Million AUD | -3084.895% |
| Botanix Pharmaceuticals Limited | -14.69 Million AUD | -858.721% |
| Island Pharmaceuticals Limited | -2.87 Million AUD | -4804.017% |
| Race Oncology Limited | -13.38 Million AUD | -953.25% |
| Nyrada Inc. | -4.56 Million AUD | -2990.362% |
| Telix Pharmaceuticals Limited | - AUD | Infinity% |
| Dimerix Limited | -25.05 Million AUD | -462.378% |
| PharmAust Limited | -6.65 Million AUD | -2016.512% |
| Immutep Limited | -44.93 Million AUD | -213.618% |
| Clarity Pharmaceuticals Ltd | -44.8 Million AUD | -214.573% |
| Alterity Therapeutics Limited | -19.6 Million AUD | -618.971% |
| BTC Health Limited | 1.05 Million AUD | 13454.727% |
| Acrux Limited | -9.83 Million AUD | -1333.096% |
| Neuren Pharmaceuticals Limited | 225.96 Million AUD | 162.369% |
| Biotron Limited | -5.15 Million AUD | -2635.897% |
| Tissue Repair Ltd | -4.87 Million AUD | -2790.322% |
| AdAlta Limited | -5.26 Million AUD | -2578.48% |
| Radiopharm Theranostics Limited | -47.2 Million AUD | -198.52% |
| Hexima Limited | -1 Million AUD | -13870.825% |
| AnteoTech Limited | -11.72 Million AUD | -1101.803% |
| Paradigm Biopharmaceuticals Limited | -65.11 Million AUD | -116.443% |
| Recce Pharmaceuticals Ltd | -22.05 Million AUD | -539.106% |
| Avecho Biotechnology Limited | -4.58 Million AUD | -2970.928% |
| Actinogen Medical Limited | -12.83 Million AUD | -997.677% |
| Immuron Limited | -5.8 Million AUD | -2329.371% |
| Argenica Therapeutics Limited | -5.67 Million AUD | -2385.023% |